A Decision Support Tool Facilitating Medicine Design for Optimal Acceptability in The Older Population

PurposeMedicine acceptability, which is of the utmost importance for vulnerable patients’ adherence, is driven by both user and product characteristics. Herein, a novel multivariate approach integrating the many aspects of acceptability is used to discriminate positively and negatively accepted medicines in the older population.MethodsAn observational study was carried out in eight hospitals and eight nursing homes to collect a large set of real-life data on medicines uses in older patients (≥65 years). Mapping and clustering explored these multiple observational measures and summarised the main information into an intelligible reference framework. Resampling statistics were used to validate the model’s reliability.ResultsA three-dimensional map and two clusters defining acceptability profiles, as positive or negative, emerged from the 1079 evaluations. Factors of interest (medicines, user features…) were positioned on the map at the barycentre of their evaluations and assigned to an acceptability profile. Focusing on patients’ ability to swallow, we have highlighted the tool’s efficacy in demonstrating the impact of user features on medicine acceptability.ConclusionsThis multivariate approach provides a relevant judgement criterion for this multi-dimensional concept. Facilitating the choice of the most appropriate dosage form to achieve optimal acceptability in a targeted population, this tool is of real potential to improve clinical decisions.

[1]  J. Josse,et al.  missMDA: A Package for Handling Missing Values in Multivariate Data Analysis , 2016 .

[2]  A. Roach,et al.  Stability of Esomeprazole Capsule Contents After In Vitro Suspension in Common Soft Foods and Beverages , 2003, Pharmacotherapy.

[3]  Anne W. Riley,et al.  Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[4]  N. Lintzeris,et al.  Bioavailability of Buprenorphine from Crushed and Whole Buprenorphine (Subutex) Tablets , 2010, European Addiction Research.

[5]  W. Haefeli,et al.  Swallowing Tablets and Capsules Increases the Risk of Penetration and Aspiration in Patients with Stroke-Induced Dysphagia , 2015, Dysphagia.

[6]  O. Ekberg,et al.  Quantitative aspects of swallowing in an elderly nondysphagic population , 2004, Dysphagia.

[7]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[8]  Joseph F Standing,et al.  Poor Formulation Information in Published Pediatric Drug Trials , 2005, Pediatrics.

[9]  P. Kozarewicz Regulatory perspectives on acceptability testing of dosage forms in children. , 2014, International journal of pharmaceutics.

[10]  P. Robert,et al.  A Unifying Tool for Linear Multivariate Statistical Methods: The RV‐Coefficient , 1976 .

[11]  W. Mourier,et al.  L’écrasement des médicaments en gériatrie : une pratique « artisanale » avec de fréquentes erreurs qui nécessitait des recommandations , 2012 .

[12]  Sébastien Lê,et al.  FactoMineR: An R Package for Multivariate Analysis , 2008 .

[13]  S. J. Kovacs,et al.  The Bioequivalence of Telithromycin Administered Orally as Crushed Tablets Versus Tablets Swallowed Whole , 2005, Journal of clinical pharmacology.

[14]  J. Kelly,et al.  Administering medication to adult patients with dysphagia. , 2009, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[15]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  J Breitkreutz,et al.  Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy. , 2012, International journal of pharmaceutics.

[17]  A. Aoussat,et al.  Standardised evaluation of medicine acceptability in paediatric population: reliability of a model , 2017, The Journal of pharmacy and pharmacology.

[18]  B. Dubois,et al.  [Mini-Mental State Examination:a useful method for the evaluation of the cognitive status of patients by the clinician. Consensual French version]. , 1999, Presse medicale.

[19]  Jérôme Pagès,et al.  Testing the significance of the RV coefficient , 2008, Comput. Stat. Data Anal..

[20]  Christian Hennig,et al.  Cluster-wise assessment of cluster stability , 2007, Comput. Stat. Data Anal..

[21]  Catherine Tuleu,et al.  Guideline on Pharmaceutical Development of Medicines for Paediatric Use , 2008 .

[22]  崎山美知代 有効性に関するトピックの動向 ICH E11‐Addendum(R1):Clinical Investigation of Medicinal Products in the Pediatric Population Lisbon2016EWG会議の報告 , 2017 .

[23]  L. Janzon,et al.  Prevalence of swallowing complaints and clinical findings among 50–79-year-old men and women in an urban population , 2006, Dysphagia.

[24]  A. Aoussat,et al.  Standardized method to assess medicines’ acceptability: focus on paediatric population , 2016, The Journal of pharmacy and pharmacology.

[25]  M. Carrier,et al.  Stability and compatibility of tegaserod from crushed tablets mixed in beverages and foods. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[26]  J. Remon,et al.  Tablet-splitting: a common yet not so innocent practice. , 2011, Journal of advanced nursing.

[27]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[28]  D. V. van Riet-Nales,et al.  Patients' appropriateness, acceptability, usability and preferences for pharmaceutical preparations: Results from a literature review on clinical evidence. , 2017, International journal of pharmaceutics.